Home Tools

CYH33

Catalog No. T38978 CAS 1494684-28-4

CYH33, an orally active and highly selective PI3Kα inhibitor, demonstrates specificity with IC50 values of 5.9 nM for the α isoform, 598 nM for β, 78.7 nM for δ, and 225 nM for γ. It effectively inhibits Akt and ERK phosphorylation and induces substantial G1 phase arrest in breast cancer and non-small cell lung cancer (NSCLC) cells, showcasing potent activity against solid tumors.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

CYH33, CAS 1494684-28-4

Pack Size	Availability	Price/USD	Quantity
5 mg	Inquiry	$ 797.00

Bulk Inquiry

Biological Description

Chemical Properties

Storage & Solubility Information

Description	CYH33, an orally active and highly selective PI3Kα inhibitor, demonstrates specificity with IC50 values of 5.9 nM for the α isoform, 598 nM for β, 78.7 nM for δ, and 225 nM for γ. It effectively inhibits Akt and ERK phosphorylation and induces substantial G1 phase arrest in breast cancer and non-small cell lung cancer (NSCLC) cells, showcasing potent activity against solid tumors.
Targets&IC50	PI3Kγ:225 nM (IC50), PI3Kα:5.9 nM (IC50), PI3Kβ:598 nM (IC50), PI3Kδ:78.7 nM (IC50)
In vitro	CYH33 exhibits potent anti-proliferative effects on breast cancer cells, inhibiting cell growth in 56% (18/32) of the lines tested with IC50 values below 1?μM. It significantly halts the cell cycle of T47D and MCF7 cells in the G1 phase in a dose-dependent manner when administered at concentrations ranging from 0.012-1 μM over 24 hours. Furthermore, exposure to CYH33 (4-1000 nM) for one hour notably suppresses the phosphorylation of ERK and Akt proteins in these cells, indicating an inhibition of key signaling pathways involved in cell proliferation and survival. However, CYH33 (0.11-1 μM) does not provoke apoptosis in MCF7 and MDA-MB-231 cells after 24 hours of treatment. Detailed cell cycle analysis revealed that CYH33 effectively induces G1 phase arrest in T47D and MCF7 cells, reducing the S phase cell population in a concentration-dependent manner, with negligible impact on the cell cycle of MDA-MB-231 cells. Western blotting confirms that CYH33 concurrently attenuates ERK and Akt phosphorylation in sensitive T47D and MCF7 cells but has minimal effect on ERK phosphorylation in resistant MDA-MB-231 cells.
In vivo	CYH33, administered orally at doses ranging from 2 to 20 mg/kg once daily for 21 days, significantly inhibits tumor growth in SCID mice implanted with human breast cancer T47D xenografts. At dosages of 10 and 20 mg/kg, CYH33 markedly reduces tumor size, achieving tumor/control (T/C) percentages of 58.36% and 49.42%, respectively. In addition, a single dose of CYH33 at 20 mg/kg notably diminishes the level of phosphorylated Akt in tumor tissues, indicating the inhibition of PI3K signaling in the nude mice. Moreover, CYH33 at a dosage of 10 mg/kg when administered once daily for either 18 or 20 days, prolongs the recovery of blood glucose levels and increases the area under the curve (AUC) for blood glucose in both T47D xenografts and R26-Pik3ca H1047R;MMTV-Cre mice models, demonstrating the compound's effect on glucose metabolism. These results highlight the potential of CYH33 as a therapeutic agent in managing breast cancer by targeting tumor growth and signaling pathways.

Molecular Weight	598.6
Formula	C24H29F3N8O5S
CAS No.	1494684-28-4

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

References and Literature

1. Haoyue Xiang, et al. Abstract LB-268: Discovery of clinical candidate methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors. AACR Annual Meeting 2018; April 14-18, 2018 2. Xue-Ling Liu, et al. Decrease in Phosphorylated ERK Indicates the Therapeutic Efficacy of a Clinical PI3Kα-selective Inhibitor CYH33 in Breast Cancer. Cancer Lett. 2018 Oct 1;433:273-282. 3. Yuxiang Wang, et al. Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer. Cancer Biol Med. 2019 Feb;16(1):66-83.

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step Two: Enter the in vivo formulation

% DMSO+

% +

% Tween 80+

% ddH₂O

%DMSO+

Calculate Reset

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL)，Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation：Take μL DMSO master liquid, next add μL PEG300， mix and clarify, next add μL Tween 80，mix and clarify, next add μL ddH₂O, mix and clarify.

Note:

Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Calculator

Molarity Calculator

Dilution Calculator

Reconstitution Calculation

Molecular Weight Calculator

Mass

Concentration

Volume

Molecular Weight

Molarity Calculator allows you to calculate the

Mass of a compound required to prepare a solution of known volume and concentration
Volume of solution required to dissolve a compound of known mass to a desired concentration
Concentration of a solution resulting from a known mass of compound in a specific volume

See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

Concentration (Start)

Volume (Start)

Concentration (End)

Volume (End)

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Molecule Formula

Molecular Weight g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

CYH33 1494684-28-4 CYH-33 CYH 33 inhibitor inhibit

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.